Single intravitreal ranibizumab for myopic choroidal neovascularization

Single intravitreal ranibizumab for myopic choroidal neovascularization

Saidin Nor-Masniwati, Ismail Shatriah, Embong ZunainaDepartment of Ophthalmology, Universiti Sains Malaysia, Kelantan, MalaysiaAbstract: We report a case of myopic choroidal neovascularization that showed improvement after a single injection of ranibizumab. A 45-year-old Chinese man with high myopia...

Full description

Bibliographic Details
Main Authors:	Shatriah I, Nor-Masniwati S, Zunaina E
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-08-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/single-intravitreal-ranibizumab-for-myopic-choroidal-neovascularizatio-a8018

Similar Items

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01)

Role of optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal injections of Ranibizumab
by: Meng Cai, et al.
Published: (2017-10-01)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
by: Ellabban AA, et al.
Published: (2012-05-01)

Myopic Choroidal Neovascularization Membranes Treated With Ranibizumab in Colombian Population
by: Hernan Andres Rios, et al.
Published: (2017-01-01)

MYOPIC CHOROIDAL NEOVASCULAR MEMBRANES TREATED WITH RANIBIZUMAB IN COLOMBIAN POPULATION
by: Hernan Andres Rios, et al.
Published: (2017-06-01)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
by: Shih-Lin Chen, et al.
Published: (2021-09-01)

Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
by: Burak Erden, et al.
Published: (2019-01-01)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
by: Jia-Kang Wang, et al.
Published: (2018-09-01)

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Endogenous Endophthalmitis
by: Shwu-Jiuan Sheu
Published: (2009-11-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Neeraj Pandey, et al.
Published: (2013-01-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Nikunj J Shah, et al.
Published: (2011-01-01)

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
by: Sidra Zafar, et al.
Published: (2016-12-01)

Efficacy of intravitreal Ranibizumab injection for choroidal neovascularization secondary to pathologic myopia
by: Li-Hong Cui, et al.
Published: (2016-03-01)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
by: Chuanfeng Fan, et al.
Published: (2014-01-01)

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye
by: Alexandr Stepanov, et al.
Published: (2020-01-01)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
by: Makri OE, et al.
Published: (2018-09-01)

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma
by: Zenith H.Y. Wu, et al.
Published: (2012-06-01)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
by: Petrou P, et al.
Published: (2013-10-01)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
by: Jay Kumar Chhablani
Published: (2010-01-01)

The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome
by: A. M. Kolomeyer, et al.
Published: (2011-01-01)

Treatment of Punctate Inner Choroidopathy with Choroidal Neovascularization Using Corticosteroid and Intravitreal Ranibizumab
by: Wei Wu, et al.
Published: (2018-01-01)

Treatment Satisfaction and Well-Being in Patients with Myopic Choroidal Neovascularization Treated with Ranibizumab in the REPAIR Study.
by: Winfried M Amoaku, et al.
Published: (2015-01-01)

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study.
by: Robin D Hamilton, et al.
Published: (2020-01-01)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
by: Rodney J Morris, et al.
Published: (2011-01-01)

Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
by: İrfan Perente, et al.
Published: (2018-04-01)

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
by: Bhurayanontachai P, et al.
Published: (2011-05-01)

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
by: Aditi Gupta, et al.
Published: (2014-01-01)

Clinical efficacy of intravitreal Ranibizumab in idiopathic choroid neovascularization type Ⅰand type Ⅱ
by: Yue-Ming Sun, et al.
Published: (2015-07-01)

Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01)

Long-term remission of myopic choroidal neovascular membrane after treatment with ranibizumab: a case report
by: Kumaran Neruban, et al.
Published: (2009-10-01)

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
by: Almila Sarıgül Sezenöz, et al.
Published: (2017-08-01)

Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab
by: Nitin Kumar, et al.
Published: (2018-01-01)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
by: Turgut Yılmaz, et al.
Published: (2017-03-01)

Bilateral choroidal neovascularization response to unilateral intravitreal Ranibizumab injection in a patient with angioid streaks
by: Otacílio de Oliveira Maia Júnior, et al.
Published: (2013-08-01)

Intravitreal ranibizumab as adjuvant treatment for neovascular glaucoma
by: Flavia Gazze Ticly, et al.
Published: (2013-04-01)

Analysis on macular choroidal thickness of patients with myopic choroidal neovascularization
by: Yan Qiu, et al.
Published: (2015-05-01)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021-06-01)

Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
by: Partha Biswas, et al.
Published: (2011-01-01)

Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Wataru Matsumiya, et al.
Published: (2011-01-01)

Clinical observation of intravitreal injection of Ranibizumab for choroidal neovascularization in patients with non- age-related macular degeneration
by: Yu-Xin Li, et al.
Published: (2016-05-01)